Nasogastric and intravenous infusions of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's disease.
- 1 February 1990
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 53 (2) , 102-105
- https://doi.org/10.1136/jnnp.53.2.102
Abstract
(+)-4-propyl-9-hydroxynaphthoxazine (PHNO) is a new dopamine agonist which is capable of producing a sustained response in parkinsonian patients with "on-off" fluctuations when given as a continuous infusion either nasogastrically or intravenously. These data suggest that a sustained release formulation of PHNO may provide a significant, new treatment for patients with "on-off" fluctuations.This publication has 15 references indexed in Scilit:
- A Strategy for Measuring the Therapeutic Properties of New Antiparkinsonian Drugs, such as + PHNO, in Patients with On-Off FluctuationsClinical Neuropharmacology, 1989
- The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary resultsMovement Disorders, 1989
- MK 458, A Selective and Potent D2 Receptor Agonist in Advanced Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Antiparkinsonian activity of single oral dose of PHNOMovement Disorders, 1987
- LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASEThe Lancet, 1986
- (+)-4-PROPYL-9-HYDROXYNAPHTHOXAZINE (PHNO), A NEW DOPAMINOMIMETIC, IN TREATMENT OF PARKINSONISMThe Lancet, 1985
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- ON-OFF FLUCTUATIONS IN PARKINSON'S DISEASEBrain, 1984